tiprankstipranks
Sinopharm Group Co Ltd Class H (HK:1099)
:1099
Hong Kong Market
1099
Sinopharm Group Co
RESEARCH TOOLSreports

Sinopharm Group Co (1099) Stock Forecast & Price Target

Compare
9 Followers
See the Price Targets and Ratings of:

1099 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Sinopharm
Group Co
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1099 Stock 12 Month Forecast

There Are No Analyst Ratings for HK:1099 In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

1099 Financial Forecast

1099 Earnings Forecast

The previous quarter’s earnings for 1099 were HK$0.67.
The previous quarter’s earnings for 1099 were HK$0.67.

1099 Sales Forecast

The previous quarter’s earnings for 1099 were HK$316.52B.
The previous quarter’s earnings for 1099 were HK$316.52B.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Huatai Securities Analyst forecast on HK:1099
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
HK$22.53
Buy
11.09%
Upside
Reiterated
03/24/26
UBS Analyst forecast on HK:1099
Unknown Analyst
UBS
Not Ranked
UBS
HK$25.7
Buy
26.73%
Upside
Reiterated
03/23/26
UBS Keeps Their Buy Rating on Sinopharm Group Co (SHTDF)
Citi Analyst forecast on HK:1099
Unknown Analyst
Citi
Not Ranked
Citi
HK$22.8
Buy
12.43%
Upside
Reiterated
03/23/26
Citi Sticks to Their Buy Rating for Sinopharm Group Co (SHTDF)
Goldman Sachs Analyst forecast on HK:1099
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
HK$19.83
Hold
-2.22%
Downside
Reiterated
03/23/26
Sinopharm Group Co (SHTDF) Gets a Hold from Goldman Sachs
HSBC Analyst forecast on HK:1099
Unknown Analyst
HSBC
Not Ranked
HSBC
HK$18→HK$19.5
Sell
-3.85%
Downside
Reiterated
11/10/25
HSBC Keeps Their Sell Rating on Sinopharm Group Co (SHTDF)
Daiwa Analyst forecast on HK:1099
Unknown Analyst
Daiwa
Not Ranked
Daiwa
HK$21
Buy
3.55%
Upside
Reiterated
10/27/25
First Shanghai Securities Analyst forecast on HK:1099
Unknown Analyst
First Shanghai Securities
Not Ranked
First Shanghai Securities
HK$21.3
Buy
5.03%
Upside
Reiterated
09/26/25
CICC Analyst forecast on HK:1099
Unknown Analyst
CICC
Not Ranked
CICC
HK$24.7
Buy
21.79%
Upside
Reiterated
08/27/25
China Renaissance Analyst forecast on HK:1099
Unknown Analyst
China Renaissance
Not Ranked
China Renaissance
HK$23.6
Buy
16.37%
Upside
Reiterated
08/26/25
UOB Kay Hian Analyst forecast on HK:1099
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
HK$17.3
Sell
-14.69%
Downside
Reiterated
08/26/25
Bank of America Securities Analyst forecast on HK:1099
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
HK$23
Buy
13.41%
Upside
Reiterated
08/25/25
Morgan Stanley Analyst forecast on HK:1099
Laurence Tam
Morgan Stanley
Morgan Stanley
HK$22.5
Buy
10.95%
Upside
Reiterated
08/22/25
Resilient Business Model and Strategic Financial Management Drive Buy Rating for Sinopharm Group
Citic Securities Analyst forecast on HK:1099
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
HK$22
Buy
8.48%
Upside
Reiterated
06/16/25
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Huatai Securities Analyst forecast on HK:1099
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
HK$22.53
Buy
11.09%
Upside
Reiterated
03/24/26
UBS Analyst forecast on HK:1099
Unknown Analyst
UBS
Not Ranked
UBS
HK$25.7
Buy
26.73%
Upside
Reiterated
03/23/26
UBS Keeps Their Buy Rating on Sinopharm Group Co (SHTDF)
Citi Analyst forecast on HK:1099
Unknown Analyst
Citi
Not Ranked
Citi
HK$22.8
Buy
12.43%
Upside
Reiterated
03/23/26
Citi Sticks to Their Buy Rating for Sinopharm Group Co (SHTDF)
Goldman Sachs Analyst forecast on HK:1099
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
HK$19.83
Hold
-2.22%
Downside
Reiterated
03/23/26
Sinopharm Group Co (SHTDF) Gets a Hold from Goldman Sachs
HSBC Analyst forecast on HK:1099
Unknown Analyst
HSBC
Not Ranked
HSBC
HK$18→HK$19.5
Sell
-3.85%
Downside
Reiterated
11/10/25
HSBC Keeps Their Sell Rating on Sinopharm Group Co (SHTDF)
Daiwa Analyst forecast on HK:1099
Unknown Analyst
Daiwa
Not Ranked
Daiwa
HK$21
Buy
3.55%
Upside
Reiterated
10/27/25
First Shanghai Securities Analyst forecast on HK:1099
Unknown Analyst
First Shanghai Securities
Not Ranked
First Shanghai Securities
HK$21.3
Buy
5.03%
Upside
Reiterated
09/26/25
CICC Analyst forecast on HK:1099
Unknown Analyst
CICC
Not Ranked
CICC
HK$24.7
Buy
21.79%
Upside
Reiterated
08/27/25
China Renaissance Analyst forecast on HK:1099
Unknown Analyst
China Renaissance
Not Ranked
China Renaissance
HK$23.6
Buy
16.37%
Upside
Reiterated
08/26/25
UOB Kay Hian Analyst forecast on HK:1099
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
HK$17.3
Sell
-14.69%
Downside
Reiterated
08/26/25
Bank of America Securities Analyst forecast on HK:1099
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
HK$23
Buy
13.41%
Upside
Reiterated
08/25/25
Morgan Stanley Analyst forecast on HK:1099
Laurence Tam
Morgan Stanley
Morgan Stanley
HK$22.5
Buy
10.95%
Upside
Reiterated
08/22/25
Resilient Business Model and Strategic Financial Management Drive Buy Rating for Sinopharm Group
Citic Securities Analyst forecast on HK:1099
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
HK$22
Buy
8.48%
Upside
Reiterated
06/16/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sinopharm Group Co

3 Months
xxx
Success Rate
4/4 ratings generated profit
100%
Average Return
+10.95%
reiterated a xxx
 rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +10.95% per trade.
1 Year
Laurence TamMorgan Stanley
Success Rate
3/4 ratings generated profit
75%
Average Return
+5.15%
reiterated a buy rating 7 months ago
Copying Laurence Tam's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +5.15% per trade.
2 Years
xxx
Success Rate
4/4 ratings generated profit
100%
Average Return
+12.70%
reiterated a xxx
 rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +12.70% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1099 Analyst Recommendation Trends

Rating
Aug 25
Sep 25
Oct 25
Nov 25
Mar 26
Strong Buy
11
10
20
17
17
Buy
0
0
0
0
0
Hold
6
14
34
31
24
Sell
1
2
2
2
1
Strong Sell
0
0
0
0
0
total
18
26
56
50
42
In the current month, 1099 has received 17 Buy Ratings, 24 Hold Ratings, and 1 Sell Ratings. 1099 average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

1099 Stock Forecast FAQ

What is HK:1099’s average 12-month price target, according to analysts?
Currently, no data Available
What is HK:1099’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:1099, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Sinopharm Group Co Ltd Class H a Buy, Sell or Hold?
      Currently, no data Available
      What is Sinopharm Group Co Ltd Class H’s share price target?
      Currently, no data Available
      What do analysts say about Sinopharm Group Co Ltd Class H?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Sinopharm Group Co Ltd Class H?
      To buy shares of HK:1099, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.